Skip to main content

Summary

What it measures:

This test assesses the time that it takes to walk a set distance, usually less than 150 feet. (Distances reported range from 8 ft to 150 ft to 400m).  Lower walking time values (or higher walking speed) represent better performance. (2)

Target Population:

People with hip and knee osteoarthritis, joint replacement, rheumatoid arthritis, older adults, and children.


You Might Also Like...

CPG

ESC/ERS 2022 Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension

Oct 7, 2022

Focuses on how pulmonary hypertension (PH) may involve multiple clinical conditions and pose complications for the majority of cardiovascular and respiratory

CPG

Canadian Cardiovascular Society 2021 Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult

Mar 26, 2021

Contains updated findings and recommendations including the use of non-fasting lipid determination as a suitable alternative to fasting levels.

CPG

Acute Coronary Syndromes [NICE NG185]

Nov 18, 2020

Recommendations on how to improve survival and quality of life for people who have a heart attack or unstable angina.